Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
A randomized, placebo-controlled, double-blind, parallel group, multi center study to assess the safety and efficacy of tiotropium bromide (18 µg) delivered via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) subjects recovering from hospitalization for an acute exacerbation (Hospital Discharge 1)
Epistemonikos ID: 41cb87cb3a5b524e1cf6b0cf8bef02a635053e65
First added on: May 11, 2024